Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the <scp>AIDA</scp> Network Uveitis Registry

ADA monotherapy could be equally effective as its combination with MTX in both preventing uveitis relapses and preserving visual acuity in paediatric NIU, with comparable retention rates over 36 months of treatment. The steroid-sparing effect of ADA monotherapy warrants further extensive evaluation to define its optimal placement in the therapeutic strategy for paediatric NIU.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Ophthalmology
Published
2025-04-04
DOI
https://doi.org/10.1111/ceo.14534
Citations
4
Primary Topic
Ocular Diseases and Behçet’s Syndrome
Type
article
Field-Weighted Citation Impact
6.83

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry

Adele Civino, Kalpana Babu Murthy, Stefano Gentileschi, Bruno Frediani et al.
4 citations
Clinical and Experimental Ophthalmology
Ocular Diseases and Behçet’s Syndrome
6.83
article

Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry

Adele Civino, Kalpana Babu Murthy, Stefano Gentileschi, Bruno Frediani, Gaafar Ragab, Maria Pia Paroli, Rana Hussein Amin, Maria Francesca Gicchino, Francesca Minoia, Ester Carreño, Maria Sole Chimenti, Emanuela Del Giudice, Valeria Caggiano, Antonio Vitale, Lampros Fotis, Paola Saboya‐Galindo, Maria Tarsia, Silvana Guerriero, Alex Fonollosa, Gian Marco Tosi, Luca Cantarini, Francesco La Torre, Germán Mejía‐Salgado, Angela Mauro, Soad Hashad, Alejandra de‐la‐Torre, Vishali Gupta, Saverio La Bella, Jurgen Sota, Mohamed Tharwat Hegazy, Carla Gaggiano, Claudia Fabiani, Luciana Breda, Stefania Costi, Rosanna Dammacco, Maria Cristina Maggio, Marco Cattalini, Giuseppe Lopalco, María Andrea Bernal‐Valencia, Halah Etayari
article en
4 citations

Abstract

ADA monotherapy could be equally effective as its combination with MTX in both preventing uveitis relapses and preserving visual acuity in paediatric NIU, with comparable retention rates over 36 months of treatment. The steroid-sparing effect of ADA monotherapy warrants further extensive evaluation to define its optimal placement in the therapeutic strategy for paediatric NIU.

Clinical and Experimental OphthalmologyVol. 53(6)
University of Siena (IT), University of Rome Tor Vergata (IT), Cairo University (EG), University of the Basque Country (ES), University of Campania "Luigi Vanvitelli" (IT), National and Kapodistrian University of Athens (GR), University of Tripoli (LY), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), BioCruces Health research Institute (ES), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Hospital Universitario Fundación Jiménez Díaz (ES), Hospital de Cruces (ES), Ospedale Pediatrico Giovanni XXIII (IT), Ospedale SS. Annunziata (IT), Ospedale Vito Fazzi (IT), ASST Fatebenefratelli Sacco (IT), Post Graduate Institute of Medical Education and Research (IN), University of Bari Aldo Moro (IT), University of Brescia (IT), Sapienza University of Rome (IT), University of Palermo (IT), Universidad del Rosario (CO)
Università degli Studi di Siena
Good health and well-being
Openalex Percentile: Top 3%
Ocular Diseases and Behçet’s Syndrome
6.83
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.